Agreed. If the acquirer overpays their SHs will crash their stock in the ST and they are answerable to them. They have to show they have made “value investing” decision in their M&A activities.
Even when M&A goes awry and the acquirers write down the value of their acquisitions over time the initial narrative around the numbers need to show some sort of future potential for the price paid. Eg. Extension of the patent timeline for their cash cow drug.
Ann: Race continues Board renewal - appoints new Chair, page-75
-
- There are more pages in this discussion • 28 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.61 |
Change
-0.055(3.31%) |
Mkt cap ! $273.4M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.68 | $1.61 | $271.5K | 166.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1996 | $1.61 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.68 | 1305 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |